MIR1297: A Potential Drug Target and Biomarker (G100302187)
MIR1297: A Potential Drug Target and Biomarker
Molecular Targets and Biomarkers
MIR1297, also known as interleukin-12 (IL-12), is a cytokine that plays a crucial role in the regulation of immune responses and has been implicated in a number of diseases, including autoimmune disorders, cancer, and obesity. Its potential as a drug target and biomarker makes it an attractive target for researchers to investigate and develop new treatments.
The IL-12 receptor is a cytokine receptor that is expressed in various tissues and cells, including immune cells, epithelial cells, and fibroblasts. IL-12 is involved in the regulation of immune responses, including the development and function of T cells, B cells, and natural killer cells. It also plays a role in the regulation of cell growth, differentiation, and survival.
MIR1297 is a cytokine that is expressed in various tissues and cells, including immune cells, epithelial cells, and fibroblasts. It is a potent stimulator of the IL-12 receptor and has been shown to promote the production of IL-12 in various tissues and cells.
MIR1297 has been shown to have a number of potential therapeutic applications. For example, it has been shown to be a potent inhibitor of the development of cancer in cell culture models. It has also been shown to be a potent regulator of obesity, particularly in obese rats.
In addition to its potential therapeutic applications, MIR1297 has also been shown to have a number of potential biomarker applications. For example, it has been shown to be a reliable biomarker for the diagnosis of obesity in rats. It has also been shown to be a reliable biomarker for the regulation of immune responses in various tissues and cells.
Overall, MIR1297 is a promising drug target and biomarker that has the potential to be used in a variety of therapeutic applications. Further research is needed to fully understand its mechanisms of action and to develop new treatments based on its potential.
Protein Name: MicroRNA 1297
The "MIR1297 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1297 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B
